Reference number
ISO/TR 12417-2:2022
© ISO 2025
Technical Report
ISO/TR 12417-2:2022
Cardiovascular implants and extracorporeal systems — Vascular device-drug combination products — Part 2: Local regulatory information
Edition 2
2022-07
Technical Report
Preview
Indisponible en français
Publiée (Edition 2, 2022)

ISO/TR 12417-2:2022

Langue
Format
CHF 155
Convertir les francs suisses (CHF) dans une autre devise

Résumé

This document provides region-specific information for:

—    local submissions and approvals for vascular device-drug combination products (VDDCPs) in countries and regions around the world;

—    changes related to the drug-containing part and how they are evaluated by different local regions.

For implanted products, this document is considered as a supplement to ISO 14630, which specifies general requirements for the performance of non-active surgical implants.

This document is considered also as a supplement to ISO 12417-1, and any relevant device-specific standards, such as the ISO 25539 series specifying requirements for endovascular devices. This document also addresses VDDCPs that are not necessarily permanent implants.

Informations générales

  • État actuel
     : Publiée
    Date de publication
     : 2022-07
    Stade
    : Norme internationale publiée [60.60]
  • Edition
     : 2
  • Comité technique :
    ISO/TC 150/SC 2
    ICS :
    11.040.40 
  • RSS mises à jour

Cycle de vie

Vous avez une question?

Consulter notre Aide et assistance

  2. Store
  3. Store
  4. TC
  5. ISO/TC 150/SC 2
  6. ISO/TR 12417-2:2022